Open Access Pre-publication history

Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer

Malek B Hannouf, Bin Xie, Muriel Brackstone and Gregory S Zaric*

BMC Cancer 2012, 12:447  doi:10.1186/1471-2407-12-447

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 06 Dec 2011
Reviewer's Report Doug Coyle 10 Jan 2012
Reviewer's Report Sonal Gandhi 08 Mar 2012
Resubmission - Version 2 Manuscript Author's comment 08 May 2012
Reviewer's Report Doug Coyle 27 May 2012
Reviewer's Report Sonal Gandhi 31 May 2012
Reviewer's Report Chris Skedgel 30 Jul 2012
Resubmission - Version 3 Manuscript Author's comment 21 Aug 2012
Editorial acceptance 23 Sep 2012
Published 02 Oct 2012